Internal Medicine, Nephrology · Sanford, NC
NPI
1538183736
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1139 Carthage St Ste 105
Sanford, NC, 27330
Phone (919) 774-2875
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
235 services
Medicare patients, 2024
116
Average age 66
Drug cost, 2024
$1.2M
511 prescriptions
Company payments, 2025
$3,031
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy K Mottl was code 99233 (hospital e&m - subsequent), 67 times for 30 patients. In total Amy K Mottl billed 235 services in 20 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 67 | 30 | $87.91 | $5,890 |
| 99214 Office E&M - Established | Office | 42 | 27 | $69.94 | $2,938 |
| 90935 Hemodialysis | Facility | 34 | 26 | $52.86 | $1,797 |
| 99223 Hospital E&M - Initial | Facility | 26 | 26 | $128.72 | $3,347 |
By year: 2022 $25K for 342 services; 2023 $15K for 214 services; 2024 $18K for 235 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy K Mottl prescribed most often to Medicare patients was Furosemide, with 34 prescriptions and refills. In total Amy K Mottl wrote 511 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 34 | 79 | 13 | $298 |
| Amlodipine Besylate Generic | 29 | 85 | Under 11 | $111 |
| Fabrazyme Agalsidase Beta | 28 | 28 | Under 11 | $701K |
| Atorvastatin Calcium Generic | 25 | 75 | Under 11 | $53.21 |
| Jardiance Empagliflozin | 21 | 63 | Under 11 | $36K |
| Losartan Potassium Generic | 19 | 57 | Under 11 | $161 |
| Farxiga Dapagliflozin Propanediol | 19 | 35 | Under 11 | $18K |
| Kerendia Finerenone | 17 | 43 | Under 11 | $27K |
| Chlorthalidone Generic | 17 | 51 | Under 11 | $246 |
| Mycophenolate Mofetil Generic | 16 | 32 | Under 11 | $2,604 |
| Metoprolol Succinate Generic | 15 | 45 | Under 11 | $328 |
| Lisinopril Generic | 13 | 39 | Under 11 | $70.73 |
| Gabapentin Generic | 13 | 36 | Under 11 | $179 |
| Allopurinol Generic | 13 | 39 | Under 11 | $128 |
| Spironolactone Generic | 12 | 36 | Under 11 | $50.76 |
Brand drugs: - claims; generic drugs: 337 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy K Mottl $3,031 ($3,031 in general payments such as food, travel and fees) from 5 companies. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $2,920.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.